Breast Neoplasms: all 12,820 studies
Page 34 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.TerminatedNCT03387085Phase 1/2Results posted
- The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer PatientsCompletedNCT03377816Not applicableResults posted
- Topical Keratin in Treating Radiation Dermatitis in Patients With Breast CancerCompletedNCT03374995Not applicableResults posted
- Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX)CompletedNCT03371732Not applicableResults posted
- DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinCompletedNCT03368196Phase 1Results posted
- Treatment of Refractory Nausea and Vomiting in Patients With Breast CancerCompletedNCT03367572Phase 3Results posted
- Breast Cancer Study of Preoperative Pembrolizumab + RadiationActive, not recruitingNCT03366844Phase 1/2Results posted
- Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast CancerCompletedNCT03366428Phase 1Results posted
- 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerCompletedNCT03364348Phase 1Results posted
- Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)CompletedNCT03359759Results posted
- Effectiveness of a Modern Educational Intervention in Breast Cancer PatientsCompletedNCT03351075Not applicableResults posted
- Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered ApproachCompletedNCT03346161Phase 1Results posted
- Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast CancerCompletedNCT03345420Phase 2Results posted
- A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast CancerCompletedNCT03344536Phase 1/2Results posted
- A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid TumorsCompletedNCT03343054Phase 1Results posted
- A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerCompletedNCT03337724Phase 3Results posted
- Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast CancerCompletedNCT03329937Phase 1Results posted
- Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) ProjectCompletedNCT03326713Not applicableResults posted
- Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After SurgeryCompletedNCT03324802Phase 3Results posted
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerCompletedNCT03323658Phase 1Results posted
- MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.CompletedNCT03321981Phase 2Results posted
- Intraoperative Detection of Residual Cancer in Breast CancerCompletedNCT03321929Phase 2Results posted
- Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryActive, not recruitingNCT03317405Phase 1Results posted
- A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast CancerCompletedNCT03316586Phase 2Results posted
- Lifestyle, Exercise, and Nutrition Study Early After DiagnosisCompletedNCT03314688Not applicableResults posted
- A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase InhibitorCompletedNCT03312738Phase 2Results posted
- Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast CancerCompletedNCT03310957Phase 1/2Results posted
- Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer SurvivorsCompletedNCT03304587Not applicableResults posted
- PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerCompletedNCT03304210Phase 1Results posted
- Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast CancerCompletedNCT03301350Phase 2Results posted
- SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast CancerCompletedNCT03294330Phase 3Results posted
- Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer PatientsCompletedNCT03289364Not applicableResults posted
- Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast CancerTerminatedNCT03289039Phase 2Results posted
- To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.CompletedNCT03286842Phase 3Results posted
- Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast CancerTerminatedNCT03284957Phase 1/2Results posted
- PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsTerminatedNCT03284723Phase 1Results posted
- Involving Family to Improve Communication in Breast Cancer CareCompletedNCT03283553Not applicableResults posted
- Decisions About Cancer Screening in Alzheimer's DiseaseCompletedNCT03282097Not applicableResults posted
- Exercise Program in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyCompletedNCT03280836Not applicableResults posted
- A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerCompletedNCT03280563Phase 1/2Results posted
- Palbociclib in Real World PracticeCompletedNCT03280303Results posted
- Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.CompletedNCT03273426Not applicableResults posted
- Her2-BATS and Pembrolizumab in Metastatic Breast CancerActive, not recruitingNCT03272334Phase 1/2Results posted
- SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerCompletedNCT03262935Phase 3Results posted
- Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesCompletedNCT03256344Phase 1Results posted
- MBSR During AI Therapy for Breast CancerCompletedNCT03253627Not applicableResults posted
- Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic ChemotherapyCompletedNCT03252431Phase 3Results posted
- A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast CancersCompletedNCT03251378Phase 1Results posted
- Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast CancerCompletedNCT03250676Phase 1/2Results posted
- A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)TerminatedNCT03248492Phase 2Results posted
- Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast CancerTerminatedNCT03241810Phase 2Results posted
- Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast CancerCompletedNCT03238196Phase 1Results posted
- Focused Ultrasound and Pembrolizumab in Metastatic Breast CancerTerminatedNCT03237572Phase 1Results posted
- Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & TaxanesCompletedNCT03222856Phase 2Results posted
- Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast TissueCompletedNCT03220893Not applicableResults posted
- Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast CancerCompletedNCT03219476Phase 2Results posted
- PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT03218826Phase 1Results posted
- Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast CancerCompletedNCT03213041Phase 2Results posted
- FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast CancerCompletedNCT03212170Phase 2Results posted
- Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative AnalgesiaCompletedNCT03210220Not applicableResults posted
- Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"CompletedNCT03209518Results posted
- Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast CancerCompletedNCT03206203Phase 2Results posted
- Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast CancerCompletedNCT03205761Phase 2Results posted
- Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing SurgeryCompletedNCT03202472Not applicableResults posted
- A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast CancerCompletedNCT03200704Phase 3Results posted
- Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerTerminatedNCT03199885Phase 3Results posted
- Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care TherapyTerminatedNCT03199040Phase 1Results posted
- A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerCompletedNCT03197935Phase 3Results posted
- Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.CompletedNCT03197389Early Phase 1Results posted
- TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast CancerCompletedNCT03193853Phase 2Results posted
- T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic RadiosurgeryTerminatedNCT03190967Phase 1/2Results posted
- Efficacy of Digital Breast Tomosynthesis + Standard 2- Dimensional Mammography in Breast CancerCompletedNCT03190083Not applicableResults posted
- Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBCTerminatedNCT03184558Phase 2Results posted
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerCompletedNCT03180294Phase 2Results posted
- Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerCompletedNCT03176238Phase 3Results posted
- Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility StudyCompletedNCT03170648Not applicableResults posted
- Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)CompletedNCT03167619Phase 2Results posted
- Hypofractionated Radiotherapy in Breast CancerCompletedNCT03167359Not applicableResults posted
- A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer PatientsCompletedNCT03165955Phase 1Results posted
- Ibrance Real World InsightsCompletedNCT03159195Results posted
- A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerActive, not recruitingNCT03155997Phase 3Results posted
- Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and BreastCompletedNCT03154281Phase 1Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- Palbociclib After CDK and Endocrine Therapy (PACE)Active, not recruitingNCT03147287Phase 2Results posted
- Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain StimulationTerminatedNCT03143894Not applicableResults posted
- Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerCompletedNCT03139435Not applicableResults posted
- Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast CancerTerminatedNCT03137693Not applicableResults posted
- What Matters Most: Choosing the Right Breast Cancer Surgery for YouCompletedNCT03136367Not applicableResults posted
- Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerCompletedNCT03132467Early Phase 1Results posted
- Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer SurvivorsCompletedNCT03131440Not applicableResults posted
- Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast CancerTerminatedNCT03130439Phase 2Results posted
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
- A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)CompletedNCT03125902Phase 3Results posted
- Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast CancerCompletedNCT03123263Results posted
- Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast CancerCompletedNCT03121352Phase 2Results posted
- Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast CancerCompletedNCT03112590Phase 1/2Results posted
- Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast CancerCompletedNCT03106415Phase 1/2Results posted
- Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast CancerCompletedNCT03106077Phase 2Results posted
- Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast CancerTerminatedNCT03101748Phase 1/2Results posted